Health Care: Drugs

Arrowhead Research Corporation (ARWR: NASDAQ)

$2.14 0.01 | 0.47%
05/21/13 - 09:29 AM ET
Company Income Statement
Sep 2012 Sep 2011 Sep 2010 Sep 2009
Sales 146.88K 296.14K 620.10K 3.77M
Cost of Sales 0.00 0.00 -339.06K -607.51K
Gross Operating Profit 146.88K 296.14K 959.16K 4.38M
Selling, General, and Administrative Expenses 14.10M 5.23M 8.00M 14.14M
Research & Development 5.39M 3.28M 1.11M 8.97M
Operating Income before D & A (EBITDA) -19.34M -8.21M -8.15M -18.73M
Depreciation & Amortization 1.76M 260.04K 654.69K 994.60K
Interest Income 35.97K 86.53K 0.00 0.00
Other Income - Net -817.24K -255.01K 1.69M 96.88K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -22.12M -8.80M -7.34M -19.16M
Interest Expense 0.00 0.00 48.02K 150.89K
Pre-Tax Income -22.12M -8.80M -7.38M -19.31M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -984.80K -363.51K -1.18M -60.00
Net Income From Continuing Operations -22.11M -8.79M -7.38M -19.31M
Net Income From Discontinued Operations -80.00 5.29M 427.34K 0.00
Net Income From Total Operations -22.11M -3.49M -6.96M -19.31M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -21.13M -3.13M -5.77M -19.31M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-22.11M -8.79M -7.38M -19.31M
Preferred Dividends
Net Income Available To Common -22.11M -8.79M -7.38M -19.31M
Basic EPS from Continuing Ops. -1.90 -1.18 -1.00 -4.30
Basic EPS from Discontinued Ops. 0.00 0.74 0.10 0.00
Basic EPS from Total Operations -1.90 -0.44 -0.90 -4.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.90 -0.44 -0.90 -4.30
Basic Normalized Net Income/Share -1.90 -1.18 -1.00 -4.30
EPS fr Continuing Ops. -1.90 -1.08 -1.00 -4.30
EPS fr Discontinued Ops 0.00 0.68 0.10 0.00
EPS fr Total Ops. -1.90 -0.40 -0.90 -4.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.90 -0.40 -0.90 -4.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.90 -1.08 -1.00 -4.30
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARWR

Latest ARWR Headlines from TheStreet

More Financial News for ARWR

Press Releases for ARWR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter